Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Non-Current Assets (2016 - 2026)

Avanos Medical's Non-Current Assets history spans 13 years, with the latest figure at $718.3 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 5.59% to $718.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 billion, a 33.52% decrease, with the full-year FY2025 number at $718.3 million, down 5.59% from a year prior.
  • Non-Current Assets hit $718.3 million in Q4 2025 for Avanos Medical, roughly flat from $716.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for AVNS hit a ceiling of $1.3 billion in Q1 2022 and a floor of $683.0 million in Q2 2025.
  • Historically, Non-Current Assets has averaged $1.1 billion across 5 years, with a median of $1.2 billion in 2021.
  • Biggest five-year swings in Non-Current Assets: increased 10.53% in 2022 and later crashed 42.3% in 2025.
  • Tracing AVNS's Non-Current Assets over 5 years: stood at $1.2 billion in 2021, then dropped by 1.12% to $1.2 billion in 2022, then grew by 3.66% to $1.2 billion in 2023, then tumbled by 36.88% to $760.8 million in 2024, then decreased by 5.59% to $718.3 million in 2025.
  • Business Quant data shows Non-Current Assets for AVNS at $718.3 million in Q4 2025, $716.3 million in Q3 2025, and $683.0 million in Q2 2025.